Health Condition 1: null- Undiagnosed Obstructive pulmonary disease with Obstructive sleep apnea
Conditions
Interventions
Intervention1: For Asthma, patients would be advised with ICS and LABA inhalers and for COPD patients the medications are LABA and LAMA inhalers.: Already marketed inhalers would be advised and stan
Sponsors
Fortis Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age is >=40 years 2. Has given consent to inclusion in the study 3. Established on CPAP for at least 3 months 4. Obstructive Spirometry
Exclusion criteria
Exclusion criteria: 1. History of Heart Failure 2. Known COPD/Asthma and on treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Incidence of airflow obstruction using 70% and 75% cut off. 2) difference in CAT score and FOSQ between the two groups 3) Activity Data (number of steps in a day) before and after LABA/LAMA 4) change in CAT test after treatment in the two groups (70% and 75% cut off) 5) change in FOSQ 6) 6 minute walk test pre and post treatment Timepoint: 1) Incidence of airflow obstruction using 70% and 75% cut off. 2) difference in CAT score and FOSQ between the two groups 3) Activity Data (number of steps in a day) before and after LABA/LAMA 4) change in CAT test after treatment in the two groups (70% and 75% cut off) 5) change in FOSQ 6) 6 minute walk test pre and post treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Change in ESS, 2.CPAP compliance Timepoint: One year | — |
Countries
India
Contacts
Public ContactDr Raja Dhar
Outcome results
None listed